Track topics on Twitter Track topics that are important to you
Enhances solubility of active pharmaceutical ingredients with poor bioavailability
Gentian violet (GV) is as effective as nystatin for treating oral candidiasis (OC) in AIDS patients, at a fraction of the cost per treatment, according to new findings. Reuters Health Information
MilliporeSigma has opened a facility in Spain dedicated to the manufacture of the solubility-enhancing excipient meglumine.
* Says launch of nystatin and triamcinolone acetonide cream, USP in U.S. Market Source text: http://bit.ly/2fYwRWZ Further company coverage:
David Salazar The drug had $119 million in sales for the 12 months ended October 2016, according to QuintilesIMS data.
About polymerbased solubility enhancement excipients for OSDFExcipients are inactive components of a drug that are used in conjunction with API. Although they are often referred to being inert, excipi...
* Receives ANDA approval for nystatin and triamcinolone acetonide cream USP, 100,000 units/gram and 1 mg/g Source text: http://bit.ly/2faznIz Further company coverage: (Bengaluru newsroom)
The FDA has approved Glenmark Pharmaceuticals' generic version of Delcor Asset's Mycolog-II, or nystatin and triamcinolone ac -More-
Nystatin A1 , a polyene macrolide antifungal antibiotic, in a slightly basic or acidic solution undergoes an intramolecular transformation, yielding a structural isomer, the translactonisation product...
We tested the antifungal potential of caffeic acid and 8 of its derivative esters against Candidaalbicans ATCC 90028 and 9 clinical isolatesand carried out a synergism assay with fluconazole and nysta...
The responses of Chinese hamster ovary epithelial cells, caused by the pore-forming agent nystatin, were investigated using brightfield and fluorescence microscopy. Different phenomena, i.e., the deta...
Compare the safety and efficacy of topical gentian violet (GV) to that of nystatin oral suspension (NYS) for the treatment of oropharyngeal candidiasis (OC) in HIV-1 infected adults in resource-limite...